Interest Expense in USD of Regen BioPharma Inc from 2013 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Regen BioPharma Inc quarterly/annual Interest Expense history and change rate from 2013 to Q1 2024.
  • Regen BioPharma Inc Interest Expense for the quarter ending 31 Mar 2024 was $17.1K, a 41.2% increase year-over-year.
  • Regen BioPharma Inc Interest Expense for the twelve months ending 31 Mar 2024 was $64K, a 29.4% decline year-over-year.
  • Regen BioPharma Inc annual Interest Expense for 2023 was $58.6K, a 57.8% decline from 2022.
  • Regen BioPharma Inc annual Interest Expense for 2022 was $139K, a 56.1% decline from 2021.
  • Regen BioPharma Inc annual Interest Expense for 2021 was $316K, a 5.22% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

Regen BioPharma Inc Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $64K $17.1K +$4.98K +41.2% 01 Jan 2024 31 Mar 2024 10-Q 24 Apr 2024
Q4 2023 $59K $17.8K +$405 +2.33% 01 Oct 2023 31 Dec 2023 10-Q 19 Jan 2024
Q3 2023 $58.6K $15.1K -$15.7K -51% 01 Jul 2023 30 Sep 2023 10-K 20 Nov 2023
Q2 2023 $74.3K $14.1K -$16.3K -53.7% 01 Apr 2023 30 Jun 2023 10-Q 25 Jul 2023
Q1 2023 $90.6K $12.1K -$30.5K -71.6% 01 Jan 2023 31 Mar 2023 10-Q 24 Apr 2024
Q4 2022 $121K $17.4K -$17.7K -50.4% 01 Oct 2022 31 Dec 2022 10-Q 19 Jan 2024
Q3 2022 $139K $30.8K -$87.2K -73.9% 01 Jul 2022 30 Sep 2022 10-K 20 Nov 2023
Q2 2022 $226K $30.4K -$29.2K -49% 01 Apr 2022 30 Jun 2022 10-Q 25 Jul 2023
Q1 2022 $255K $42.6K -$22.7K -34.8% 01 Jan 2022 31 Mar 2022 10-Q 18 Apr 2023
Q4 2021 $278K $35K -$38.2K -52.2% 01 Oct 2021 31 Dec 2021 10-Q 19 Jan 2023
Q3 2021 $316K $118K +$36.6K +44.9% 01 Jul 2021 30 Sep 2021 10-K 15 Nov 2022
Q2 2021 $279K $59.6K -$21.8K -26.8% 01 Apr 2021 30 Jun 2021 10-Q 22 Jul 2022
Q1 2021 $301K $65.2K -$16.8K -20.5% 01 Jan 2021 31 Mar 2021 10-Q 21 Apr 2022
Q4 2020 $318K $73.2K -$15.4K -17.4% 01 Oct 2020 31 Dec 2020 10-Q 20 Jan 2022
Q3 2020 $333K $81.4K -$1.13K -1.37% 01 Jul 2020 30 Sep 2020 10-K 22 Dec 2021
Q2 2020 $335K $81.3K +$10.7K +15.1% 01 Apr 2020 30 Jun 2020 10-Q/A 22 Dec 2021
Q1 2020 $324K $82K +$13.9K +20.4% 01 Jan 2020 31 Mar 2020 10-Q 05 Aug 2021
Q4 2019 $310K $88.6K +$14.8K +20.1% 01 Oct 2019 31 Dec 2019 10-Q 05 Aug 2021
Q3 2019 $295K $82.5K +$17.6K +27% 01 Jul 2019 30 Sep 2019 10-K 04 Aug 2021
Q2 2019 $278K $70.7K +$7.07K +11.1% 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2021
Q1 2019 $271K $68.1K +$2.97K +4.56% 01 Jan 2019 31 Mar 2019 10-Q 05 Aug 2021
Q4 2018 $268K $73.8K +$8.49K +13% 01 Oct 2018 31 Dec 2018 10-Q 05 Aug 2021
Q3 2018 $259K $65K +$21.4K +49.2% 01 Jul 2018 30 Sep 2018 10-K 21 Jun 2021
Q2 2018 $238K $63.6K +$35.6K +127% 01 Apr 2018 30 Jun 2018 10-Q 24 Oct 2019
Q1 2018 $202K $65.1K +$49.8K +325% 01 Jan 2018 31 Mar 2018 10-Q 29 Aug 2019
Q4 2017 $152K $65.3K +$53.4K +448% 01 Oct 2017 31 Dec 2017 10-Q 12 Feb 2019
Q3 2017 $98.8K $43.6K +$34.6K +388% 01 Jul 2017 30 Sep 2017 10-K 27 Dec 2018
Q2 2017 $64.2K $28K +$19.2K +218% 01 Apr 2017 30 Jun 2017 10-Q 06 Aug 2018
Q1 2017 $45K $15.3K +$10.2K +201% 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018
Q4 2016 $34.7K $11.9K +$6.92K +138% 01 Oct 2016 31 Dec 2016 10-Q 27 Jan 2017
Q3 2016 $27.8K $8.93K +$5.98K +203% 01 Jul 2016 30 Sep 2016 10-K 21 Dec 2016
Q2 2016 $21.8K $8.8K +$5.29K +151% 01 Apr 2016 30 Jun 2016 10-Q 01 Aug 2016
Q1 2016 $16.5K $5.09K -$4.1K -44.6% 01 Jan 2016 31 Mar 2016 10-Q 29 Apr 2016
Q4 2015 $20.6K $5K -$1.04K -17.2% 01 Oct 2015 31 Dec 2015 10-Q 27 Jan 2017
Q3 2015 $21.7K $2.95K +$734 +33.2% 01 Jul 2015 30 Sep 2015 10-K 21 Dec 2016
Q2 2015 $21K $3.51K +$3.51K 01 Apr 2015 30 Jun 2015 10-Q 01 Aug 2016
Q1 2015 $17.4K $9.19K +$9.19K 01 Jan 2015 31 Mar 2015 10-Q 29 Apr 2016
Q4 2014 $8.25K $6.04K +$6.04K 01 Oct 2014 31 Dec 2014 10-Q/A 28 Apr 2017
Q3 2014 $2.21K $2.21K 01 Jul 2014 30 Sep 2014 10-K/A 28 Apr 2017
Q2 2014 $0 01 Apr 2014 30 Jun 2014 10-Q/A 28 Apr 2017
Q1 2014 $0 01 Jan 2014 31 Mar 2014 10-Q/A 28 Apr 2017
Q4 2013 $0 01 Oct 2013 31 Dec 2013 10-Q 04 Feb 2015

Regen BioPharma Inc Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $58.6K -$80.1K -57.8% 01 Oct 2022 30 Sep 2023 10-K 20 Nov 2023
2022 $139K -$177K -56.1% 01 Oct 2021 30 Sep 2022 10-K 20 Nov 2023
2021 $316K -$17.4K -5.22% 01 Oct 2020 30 Sep 2021 10-K 15 Nov 2022
2020 $333K +$38.2K +13% 01 Oct 2019 30 Sep 2020 10-K 22 Dec 2021
2019 $295K +$36.1K +13.9% 01 Oct 2018 30 Sep 2019 10-K 04 Aug 2021
2018 $259K +$160K +162% 01 Oct 2017 30 Sep 2018 10-K 21 Jun 2021
2017 $98.8K +$71K +255% 01 Oct 2016 30 Sep 2017 10-K 27 Dec 2018
2016 $27.8K +$6.14K +28.3% 01 Oct 2015 30 Sep 2016 10-K 21 Dec 2016
2015 $21.7K +$19.5K +880% 01 Oct 2014 30 Sep 2015 10-K 21 Dec 2016
2014 $2.21K +$2.21K 01 Oct 2013 30 Sep 2014 10-K/A 28 Apr 2017
2013 $0 01 Oct 2012 30 Sep 2013 10-K 18 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.